Skip to main content

Cannabis patients from Ticino are also beginning to tell their stories in the media

A recent article from Ticino highlights how difficult the situation remains for many cannabis patients in Switzerland. Although cannabis has been legally prescribed for medical purposes since 2022, those affected still struggle with significant stigma, a lack of social acceptance, and considerable problems with health insurance coverage.

The article from Ticino tells, among other things, the story of a patient with multiple sclerosis from the Bellinzona area. She reports that cannabis helped her better control her symptoms and manage her daily life. The therapy was initially covered by her health insurance. However, the coverage was later abruptly stopped.

The patient says:
"I never used drugs for intoxication or pleasure. But this forces me to turn to dealers."

This statement vividly illustrates the absurd situation of many affected individuals: Although cannabis is legally prescribed and medically helpful, patients are put under enormous pressure due to a lack of support from health insurance companies.

The article also features patient Emanuele Barbera, who speaks openly about his situation. Both stories illustrate how burdensome the current situation has become for those affected. The demands for repayment from health insurance companies are particularly dramatic. In some cases, patients suddenly have to repay very large sums, even though the therapy was previously approved and paid for.

These demands for repayment cause enormous psychological stress for many of those affected. Many fear losing their treatment or falling into serious financial difficulties. For chronically ill people, this uncertainty often means an additional, massive burden in their daily lives.

Dr. Giuseppe Plebani, a physician from Ticino who specializes in cannabinoids, also points out in the article how problematic this development is. He explains that it forces patients onto the black market, where contaminated or dangerous products circulate, potentially laced with synthetic THC, benzodiazepines, or even fentanyl. This is precisely what medically supervised therapy should prevent.

This problem affects not only Ticino, but all of Switzerland. As the MEDCAN Association , we regularly receive similar feedback from all regions of the country. Nevertheless, the article particularly vividly illustrates how difficult the situation remains for those affected in Ticino. The stigma surrounding medical cannabis seems to be especially strong in Ticino. Many patients hardly dare to speak openly about their therapy because cannabis is still heavily stigmatized in society and, in some cases, very conservative views prevail.

That makes it all the more important and courageous when those affected begin to share their stories publicly. Personal experiences help to show others how cannabis can help in medicine and what reality many chronically ill people experience daily.

As Association MEDCAN, we regularly publish stories from our members to educate, reduce prejudice and change the stigma surrounding cannabis in medicine in the long term.

You can find the full article here:

Tio.ch – «May fumato per sballo or divertimento. My così mi costringono a rivolgermi agli spacciatori»